|
gptkbp:instanceOf
|
gptkb:biotechnology
gptkb:public_company
|
|
gptkbp:CEO
|
gptkb:Stéphane_Bancel
|
|
gptkbp:collaboratedWith
|
gptkb:National_Institutes_of_Health
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:CUSIP
|
60770K107
|
|
gptkbp:developedVaccineFor
|
gptkb:COVID-19
|
|
gptkbp:foundedYear
|
2010
|
|
gptkbp:founder
|
gptkb:Robert_S._Langer
gptkb:Derrick_Rossi
gptkb:Noubar_Afeyan
gptkb:Timothy_Springer
gptkb:Kenneth_Chien
|
|
gptkbp:headquartersLocation
|
gptkb:Cambridge,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Moderna Inc.
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:ISIN
|
US60770K1079
|
|
gptkbp:keyPerson
|
gptkb:Jorge_Gomez
gptkb:Juan_Andres
gptkb:Melissa_J._Moore
gptkb:Noubar_Afeyan
gptkb:Paul_Burton
gptkb:Stéphane_Bancel
gptkb:Stephen_Hoge
gptkb:Tal_Zaks
gptkb:Andrea_Carfi
gptkb:Corinne_Le_Goff
gptkb:Hamilton_Bennett
gptkb:Jamey_Mock
gptkb:Kate_Cronin
gptkb:Lori_Henderson
gptkb:Marcello_Damiani
gptkb:Ray_Jordan
gptkb:Shannon_Thyme_Klinger
gptkb:Tracey_Franklin
gptkb:Zachary_D._Hornby
gptkb:Brad_Miller
|
|
gptkbp:listedOn
|
gptkb:NASDAQ
|
|
gptkbp:logo
|
Moderna logo.svg
|
|
gptkbp:marketCap
|
tens of billions USD (2023)
|
|
gptkbp:netIncome
|
$8.4 billion (2022)
|
|
gptkbp:notableProduct
|
gptkb:Spikevax
gptkb:mRNA-1273
|
|
gptkbp:numberOfEmployees
|
approximately 4,000 (2023)
|
|
gptkbp:parentCompany
|
independent
|
|
gptkbp:receivedEmergencyUseAuthorization
|
December 2020 (COVID-19 vaccine)
|
|
gptkbp:researchInterest
|
infectious diseases
oncology
cardiovascular diseases
rare diseases
|
|
gptkbp:revenue
|
$19.3 billion (2022)
|
|
gptkbp:specializesIn
|
vaccine development
mRNA therapeutics
|
|
gptkbp:stockSymbol
|
gptkb:MRNA
|
|
gptkbp:tradedOn
|
gptkb:NASDAQ
|
|
gptkbp:website
|
https://www.modernatx.com/
|
|
gptkbp:bfsParent
|
gptkb:^NDX
|
|
gptkbp:bfsLayer
|
6
|